Sorry, unable to follow Marco. Please try again.
Global Marketing, Market Access and Business Development professional with experience across pharma and diagnostics, focused on hematology, oncology, rare disease, cardiovascular, metabolic disorders and international launch execution. I support global and regional commercial strategy through product launches, market access evaluation, business cases, forecasting, KOL engagement, advisory boards, HCP campaigns, sales force training, digital assets, CRM systems, and affiliate localization. My experience includes roles at Pharma&, Roche, AstraZeneca Rare Disease, and Bayer, working across international markets and cross-functional teams.
• Dual role as European Marketing Specialist (50%) and Global Market Access Specialist (50%). • Therapeutic area experience in oncology, hematology, and gynecologic oncology, with a focus on rare hematologic diseases and advanced ovarian cancer. • Led the launch of a new European campaign for a treatment in polycythemia vera and essential thrombocythemia, within hematologic oncology and rare diseases, in collaboration with key countries. Developed the brand identity from scratch and supported implementation through training for local affiliates. • Led the launch of a new European campaign for a treatment in polycythemia vera and essential thrombocythemia. Developed the brand identity from scratch and supported implementation through training for local affiliates. • Managed the continuous evolution of an existing campaign for advanced ovarian cancer, including the development of objection handlers, core materials, and international congress activities, from booth execution to physician engagement. • Delivered significant budget optimization, reducing selected costs by 70% versus the previous year while maintaining high-quality deliverables. • As a Market Access Specialist, collaborated with country affiliates and external partners to prepare and submit reimbursement dossiers for oncology and hematology products, while working with local agencies to ensure the effective implementation of the agreed market access strategy. • Conducted research to support premium pricing strategies while expanding international reimbursement coverage for the company’s oncology and hematology products.
• Managed global marketing campaigns for cardiovascular biomarkers, including NT-proBNP, Troponin, and Lp(a). • Led global content development for Lp(a), coordinating an international squad across the US, EU5, Middle East, and APAC. • Managed the lifecycle of global campaign assets, from agency creation and affiliate localization to performance analysis. • Within the pipeline team (R&D), I am in charge of conducting research using internal and external data in order to assess the possibility of launching a biomarker to diagnose patients with cardiovascular disease/rare disease. I am also in charge of assessing possible development or commercial partnerships with pharmaceutical companies and then reporting the outcomes to senior leaders. • Utilized project planning tools to track and communicate critical path activities for the 'Gold Campaign' managing the entire lifecycle from asset creation to localization and performance analysis, ensuring timely achievement of project milestones and adherence to quality standards. • Initiated a sales force training program with an external agency and identified key areas of growth potential and strategies to increase both short- and long-term growth. • Worked together with another IPM and our R&D team to differentiate our NT-proBNP test from that of a competitor and to protect NT-proBNP after patent expiry
• Dual role as International Marketing Specialist: 40% with metabolic team and 60% with hematology and nephrology team. • Global Project Manager for the launch of new molecule. Coordinated the production of assets (sales aid and messaging framework) and the launch in Germany, Switzerland, and Austria. • I actively engaged with KOLs and other stakeholders, effectively communicating the unmet needs in the field and highlighting the value of our drug and the importance of early diagnosis for our patients. • Created a new messaging framework, sales aid, and infographic (both branded and unbranded assets) with an external agency to protect Ultomiris after patent expiry. Developed a global strategy to highlight pharmacokinetic/pharmacodynamic (PK/PD) data and demonstrate the therapy's high value for patients. I started a sales force training in collaboration with the medical team • Established a squad with the regional CRM manager and six country managers to monitor the performance of our marketing campaigns. Launched HCP and patient websites, leveraging approved marketing materials, SEO and integrating Google Analytics • Launched a webinar series for aHUS and PNH. Set up dedicated SpotMe pages and developed a pre-approved email flow for all TAs to promote their webinars. Partnered with the medical team to engage 10 KOLs as speakers and define the slide deck content, highlighting their positive experiences with our drug, and included a dedicated Q&A session to enhance connections among HCPs
• Demonstrated excellent ability to work and communicate effectively within cross-functional teams, including developing the Integrated Brand Plan (IBP) for a new drug. • Created innovative promotional materials for industry congresses, branded and unbranded sales aid and medical deck. • Gained experience interacting with clinicians at national conferences (Italian Society of Diabetology) and collaborating with external agencies to localize the assets received from the global team. • Participated in proposing innovative activities and managed budget. Developed skills in segmentation and targeting of patients and key accounts (adoption ladder and patient funnel) • Collaborated with six Medical Science Liaisons (MSLs) deployed in key regions to develop a strategic plan for integrating new sales representatives, leveraging critical insights gathered by the MSLs to create a comprehensive and effective foundation for our sales force training program.